These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28128657)

  • 21. Hyperglycemia and perioperative glucose management.
    Duncan AE
    Curr Pharm Des; 2012; 18(38):6195-203. PubMed ID: 22762467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
    Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
    Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.
    Ahrén B
    Vasc Health Risk Manag; 2013; 9():155-63. PubMed ID: 23637538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A primer for achieving glycemic control in the cardiac surgical patient.
    McDonnell ME; Alexanian SM; White L; Lazar HL
    J Card Surg; 2012 Jul; 27(4):470-7. PubMed ID: 22640228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Avogaro A; Bonora E; Consoli A; Del Prato S; Genovese S; Giorgino F
    Diab Vasc Dis Res; 2019 Sep; 16(5):399-414. PubMed ID: 31044622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology and Perioperative Considerations for Diabetes Mellitus Medications.
    Aniskevich S; Renew JR; Chadha RM; Irizarry-Alvarado JM
    Curr Clin Pharmacol; 2017; 12(3):157-163. PubMed ID: 28799484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes.
    Dhatariya K; Levy N; Kilvert A; Watson B; Cousins D; Flanagan D; Hilton L; Jairam C; Leyden K; Lipp A; Lobo D; Sinclair-Hammersley M; Rayman G;
    Diabet Med; 2012 Apr; 29(4):420-33. PubMed ID: 22288687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualised treatment targets in patients with type-2 diabetes and hypertension.
    Schmieder RE; Tschöpe D; Koch C; Ouarrak T; Gitt AK;
    Cardiovasc Diabetol; 2018 Jan; 17(1):18. PubMed ID: 29357854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative Management of Diabetes Mellitus: Novel Approaches.
    Palermo NE; Garg R
    Curr Diab Rep; 2019 Feb; 19(4):14. PubMed ID: 30806818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world prevalence of mild to moderate hypoglycemic episodes in type 2 diabetes in Portugal: Results from the HIPOS-PHARMA study.
    Torre C; Guerreiro JP; Romano S; Miranda A; Longo P; Alão S; Conceição J; Laires P
    Prim Care Diabetes; 2018 Dec; 12(6):537-546. PubMed ID: 30017600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes.
    Yun JS; Ko SH
    Korean J Intern Med; 2015 Jan; 30(1):6-16. PubMed ID: 25589828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novo Nordisk incretin and Cardiovascular Summit, Durban, June 2013.
    Wagenaar P
    Cardiovasc J Afr; 2013 Sep; 24(8):340. PubMed ID: 24240386
    [No Abstract]   [Full Text] [Related]  

  • 33. The Need to Change Regulatory Evaluation of Hypoglycemia in Trials of Diabetes Treatments.
    Klonoff DC; Fleming A; Gabbay R
    J Diabetes Sci Technol; 2020 Nov; 14(6):987-989. PubMed ID: 31744326
    [No Abstract]   [Full Text] [Related]  

  • 34. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
    Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
    Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative management of patients with diabetes undergoing ambulatory elective surgery.
    Coan KE; Schlinkert AB; Beck BR; Haakinson DJ; Castro JC; Schlinkert RT; Cook CB
    J Diabetes Sci Technol; 2013 Jul; 7(4):983-9. PubMed ID: 23911180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safe and appropriate use of insulin and other antihyperglycemic agents in hospital.
    Cornish W
    Can J Diabetes; 2014 Apr; 38(2):94-100. PubMed ID: 24690504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Divergent effects of various diabetes drugs on cardiovascular prognosis.
    Bell DS; Patil HR; O'Keefe JH
    Rev Cardiovasc Med; 2013; 14(2-4):e107-22. PubMed ID: 24448252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoglycemia. Pathophysiology and treatment.
    Herbel G; Boyle PJ
    Endocrinol Metab Clin North Am; 2000 Dec; 29(4):725-43. PubMed ID: 11149159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
    Kostev K; Dippel FW; Rathmann W
    Prim Care Diabetes; 2014 Jul; 8(2):127-31. PubMed ID: 24183472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on Management of Type 2 Diabetes for Cardiologists.
    Qureshi M; Gammoh E; Shakil J; Robbins R
    Methodist Debakey Cardiovasc J; 2018; 14(4):273-280. PubMed ID: 30788013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.